Nektar Therapeutics
NKTR
#6053
Rank
โ‚น95.75 B
Marketcap
โ‚น2,799
Share price
-7.19%
Change (1 day)
-42.45%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): -โ‚น612.81

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น620.89. In 2025 the company made an earnings per share (EPS) of -โ‚น945.23 a decrease over its 2024 EPS that were of -โ‚น821.06.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น612.81-35.17%
2025-โ‚น945.2315.12%
2024-โ‚น821.06-59.54%
2023-โ‚น2,029-25.89%
2022-โ‚น2,738-31.12%
2021-โ‚น3,97614.86%
2020-โ‚น3,461-1.19%
2019-โ‚น3,503-163.96%
2018โ‚น5,477-725.4%
2017-โ‚น875.73-42.73%
2016-โ‚น1,52983.33%
2015-โ‚น834.0339.53%
2014-โ‚น597.72-69.29%
2013-โ‚น1,946-6.67%
2012-โ‚น2,085

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น619.02-199.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น65.80-110.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,611-359.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น130.66-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.03-114.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น659.81-206.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น55.60-108.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-โ‚น0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland